PREMATURITY; EXTREME
Clinical trials for PREMATURITY; EXTREME explained in plain language.
Never miss a new study
Get alerted when new PREMATURITY; EXTREME trials appear
Sign up with your email to follow new studies for PREMATURITY; EXTREME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple drug combo save tiny preemies from deadly lung disease?
Disease control OngoingThis study tests whether adding budesonide (an anti-inflammatory drug) to standard surfactant therapy helps extremely preterm babies (born before 29 weeks or weighing under 2.2 pounds) avoid severe chronic lung disease or death. About 640 infants will receive either the combinati…
Matched conditions: PREMATURITY; EXTREME
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated May 17, 2026 05:37 UTC
-
Protein-Pumped breast milk may boost growth in tiniest babies
Disease control OngoingThis study looks at whether giving extremely preterm babies (born at 28 weeks or earlier) breast milk with extra protein during their first two weeks of life helps them gain more lean muscle and develop a healthier mix of gut bacteria. About 150 infants will be enrolled and follo…
Matched conditions: PREMATURITY; EXTREME
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 17, 2026 05:31 UTC